Origin Stories
EXPLORING THE MOMENTS THAT SPARK NEW POSSIBILITIES
Knowing When to Transition Your Pharmaceutical Discovery to Pre-IND Work: 6 Key Indicators
Transitioning a pharmaceutical project from the discovery stage to pre-IND work is a momentous step. Here are six critical checkpoints to confirm before taking the leap.
Transitioning from Drug Discovery to Pre-IND Work
The path of a compound from identification in drug discovery to the commencement of formal human trials is marked by a crucial transitional phase — the pre-IND work.
Women in Phage Display: Dr. Susan Deutscher
As we celebrate Women's History Month, we recognize the many women scientists who have contributed to the advancement of phage display technology.
Key Advantages of Phage Display in Drug Discovery
Phage display is a powerful tool used in drug discovery to develop peptides and monoclonal antibodies. Here we give a brief overview of its key advantages.
Movember and Prostate Cancer Research
Movember raises awareness about men's health issues including prostate cancer. At Cell Origins, we explore how phage display contributes to prostate cancer research.
Cell Origins — Pioneers in Phage Display Technology
Cell Origins is a women-owned business founded by scientists trained at the University of Missouri, where phage display was pioneered by Nobel laureate George Smith.
Celebrating Women's Business Month – Cell Origins
October is Women's Business Month. At Cell Origins, we celebrate women-owned businesses and the women scientists driving innovation in phage display.
Biopanning of Phage Display Libraries
Biopanning is the most common method for selecting and identifying peptides and antibodies that bind to a target antigen from a phage display library.
Phage Display Libraries
Phage display technology is used to select and identify peptides, monoclonal antibodies, or proteins that bind to a specific target molecule.
Phage Display: Bacteriophage Vectors and Phagemids
Phage display technology was developed by Dr. George P. Smith in 1985. This post explores the bacteriophage vectors and phagemids that make phage display possible.